Chronic Liver Disease: Clinical Trials

124 trials for Chronic Liver Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed, 30 unknown, 15 recruiting, 8 terminated. 43 Not applicable, 12 Phase 4, 11 Phase 2, 10 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable43Completed 25, Unknown 6, Recruiting 5, Terminated 3, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Phase 412Completed 6, Unknown 4, Recruiting 1, Terminated 1
Phase 211Completed 7, Terminated 2, Not yet recruiting 1, Unknown 1
Phase 310Completed 6, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Phase 13Completed 2, Unknown 1

Follow Chronic Liver Disease: new trials by email Literature Review of Chronic Liver Disease trials Research Report on Chronic Liver Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement
Repeated EUS-Guided Portal Pressure Gradient Measurement - Portal Hypertension, Chronic Liver Disease
Not yet recruitingUniversity Hospital Muenster1502027-01-012026-10-16
Baveno VIII Criteria for Portal Hypertension in Egyptian Patients
Compensated Liver Disease, Esophageal Varices
Not yet recruitingAssiut University1252026-09-262026-09-25
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.
Ursodeoxycholic acid, Standard Medical Treatment - Chronic Liver Disease
Not applicableNot yet recruitingInstitute of Liver and Biliary Sciences, India1302026-06-182026-06-23
Copper Supplementation in Cirrhosis
Copper Gluconate - Cirrhosis, Chronic Liver Disease
Not applicableRecruitingUniversity of Washington302026-03-152026-03-13
Endoscopic Ultrasound Shear Wave Elastography Study
Endoscopic Ultrasound Shear Wave Elastography (EUS) and Attenuation Imaging, FibroScan, Liver biopsy - MASLD, MASH
RecruitingOlympus Corporation of the Americas3002025-09-032025-09-15
Referral of Patients to Hepatology With Hepatoscope
Hepatoscope - Chronic Liver Disease
Not applicableRecruitingUniversity Hospital, Antwerp2002025-08-222026-05-08
To Study the Clinical Course and Outcomes of Non-electively Hospitalised Patients of Chronic Liver Disease (CLD) With Hepatic or Extra-hepatic Predominant Organ Failure(s) at 6 Months.
No Intervention - Chronic Liver Disease
RecruitingInstitute of Liver and Biliary Sciences, India1002025-04-152026-08-11
Comparing Portal Vein Assessment by Intraoperative Doppler and Transesophageal Echocardiography
Transesophageal echocardiography - Chronic Liver Disease
CompletedInstitute of Liver and Biliary Sciences, India252025-04-052025-06-26
Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease
High volume Plasma Exchange, Standard Medical Treatment - Drug Induced Liver Injury, Chronic Liver Disease
Phase 2 / Phase 3Not yet recruitingInstitute of Liver and Biliary Sciences, India962025-01-252025-01-28
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
blood sampling - Chronic Liver Disease
Not applicableRecruitingUniversity Hospital, Limoges7562024-12-092025-02-12
Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant
Rifaximin 550 MG, SOC - Chronic Liver Disease
Not applicableRecruitingInstitute of Liver and Biliary Sciences, India1002024-12-012025-03-05
Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver Diseases
Mobile chat messaging, Screening, brief intervention and referral to treatment - Chronic Liver Disease
Not applicableActive not recruitingThe University of Hong Kong1062024-10-022026-09-21
Somatic Mutation in Chronic Liver Disease
No intervention - Chronic Liver Disease, Somatic Mutation
UnknownThe Wellcome Sanger Institute2502024-07-072024-10-24
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
LAENNEC (Human Placenta Hydrolysate) IV, LAENNEC (Human Placenta Hydrolysate) SC - Chronic Liver Disease
Phase 3RecruitingGreen Cross Wellbeing2262024-07-012026-02-25
Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia
Chronic Liver Disease, Thrombopenia
CompletedBeijing Ditan Hospital1082024-06-202026-07-21
hepatomiR cACLD Study
hepatomiR - Chronic Liver Disease and Cirrhosis, Chronic Liver Disease
RecruitingKarl Landsteiner University of Health Sciences1562024-05-152026-08-21
Measuring Patient Reported Needs in Outpatient Liver Disease Management
Chronic Liver Disease, Cirrhosis, Liver
RecruitingIndiana University4002024-03-052026-07-29
An Observational Study of Patients With Chronic Liver Disease
Observational - Chronic Liver Disease, Cirrhosis
Enrolling by invitationTarget PharmaSolutions, Inc.5000002024-02-192026-03-03
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
Chronic Liver Disease
Not yet recruitingJohannes Gutenberg University Mainz2502024-01-152024-01-03
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
underling disease - Chronic Liver Disease, Malignant Tumor
UnknownThe Second Affiliated Hospital of Chongqing Medical University4802023-08-012023-08-03

Showing 20 of 124. Sign in to see all of them.

Narrower conditions

Fibrosis (25)  ·  Liver Cirrhosis (20)  ·  Carcinoma, Hepatocellular (12)  ·  Non-alcoholic Fatty Liver Disease (8)  ·  Hypertension, Portal (7)  ·  Hepatitis C (5)  ·  Inflammatory Bowel Diseases (5)  ·  Chemical and Drug Induced Liver Injury (4)  ·  Hepatitis B (4)  ·  Thrombocytopenia (4)  ·  Diabetes Mellitus (3)  ·  Esophageal and Gastric Varices (3)  ·  Fatty Liver (3)  ·  Hypertension (3)  ·  Liver Diseases (3)

Broader conditions

Digestive System Diseases (59)  ·  Pathological Conditions, Signs and Symptoms (51)  ·  Liver Diseases (49)  ·  Pathologic Processes (47)  ·  Fibrosis (17)  ·  Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Infections (13)  ·  Adenocarcinoma (12)  ·  Carcinoma (12)  ·  Digestive System Neoplasms (12)  ·  Neoplasms by Histologic Type (12)  ·  Neoplasms, Glandular and Epithelial (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Virus Diseases (12)

Interventions

Elasticity Imaging Techniques (4)  ·  Tumor Necrosis Factor-alpha (3)  ·  Ursodeoxycholic Acid (3)  ·  Lactulose (2)  ·  pirfenidone (2)  ·  Amino Acids, Branched-Chain (1)  ·  Audiovisual Aids (1)  ·  BNT162 Vaccine (1)  ·  Blood Specimen Collection (1)  ·  Carvedilol (1)  ·  Catheter Ablation (1)  ·  ChAdOx1 nCoV-19 (1)  ·  Cholecalciferol (1)  ·  Clinical Protocols (1)  ·  Colesevelam Hydrochloride (1)

Sponsors

Institute of Liver and Biliary Sciences, India (14)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (4)  ·  Meridian Bioscience, Inc. (4)  ·  Assiut University (3)  ·  Massachusetts General Hospital (3)  ·  PharmaKing (3)  ·  Chuncheon Sacred Heart Hospital (2)  ·  Green Cross Wellbeing (2)  ·  Humanity & Health Medical Group Limited (2)  ·  University of Medicine and Pharmacy Craiova (2)  ·  VA Connecticut Healthcare System (2)  ·  Asian Institute of Gastroenterology, India (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Association HGE CHU Bordeaux Sud (1)  ·  Azienda Ospedaliera di Padova (1)

Countries

United States (23)  ·  India (18)  ·  South Korea (12)  ·  France (11)  ·  Germany (7)  ·  Canada (6)  ·  Italy (5)  ·  Taiwan (5)  ·  Belgium (4)  ·  China (4)  ·  Israel (4)  ·  Austria (3)  ·  Hong Kong (3)  ·  Romania (3)  ·  Spain (3)

Top investigators

Adrian Saftoiu, MD, PhD (2)  ·  Dr Seema Alam, MD (2)  ·  Guadalupe Garcia-Tsao, MD (2)  ·  Jen-Eing Jeng, M.D. (2)  ·  Jung-Fa Tsai, M.D., Ph.D. (2)  ·  Minho Lee, MD.PhD (2)  ·  Adrian Rueben, MD (1)  ·  Alexander Fich, MD (1)  ·  Ali Asad Khan, FCPS (1)  ·  Aliena Badshah (1)  ·  Anam Ali, MS (1)  ·  Andreas Maieron, PD Dr. (1)  ·  Andrew Trout, M.D. (1)  ·  Anthony E Samir, MD (1)  ·  Arthur McCullough, MD (1)

Results publications

PMID 11495032, PMID 16400329, PMID 17622601, PMID 19723493, PMID 19880582, PMID 20683930, PMID 20852905, PMID 21736776, PMID 22913681, PMID 22943930, PMID 23840211, PMID 24840288, PMID 24902119, PMID 25546176, PMID 25749502, PMID 25941185, PMID 26503488, PMID 26744140, PMID 27893402, PMID 27896451, PMID 28186630, PMID 28679676, PMID 28695342, PMID 29289383, PMID 29364196, PMID 29503247, PMID 29607050, PMID 29638020, PMID 30635055, PMID 31011303, PMID 31305281, PMID 31592079, PMID 32205226, PMID 32348643, PMID 32617767, PMID 32813194, PMID 32950749, PMID 32964510, PMID 33123384, PMID 33227281, PMID 33713486, PMID 34895316, PMID 35904722, PMID 36274113, PMID 37078544, PMID 37605251, PMID 37831433, PMID 38141686, PMID 38367972, PMID 39045811

NIH funding

2014 (1), R01DK142802 (1)